Clinical heterogeneity of patients with stool samples testing PCR+/Tox− from a two-step Clostridium difficile diagnostic algorithm
- 20 September 2018
- journal article
- research article
- Published by Springer Science and Business Media LLC in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 37 (12), 2355-2359
- https://doi.org/10.1007/s10096-018-3383-7
Abstract
The clinical significance of indeterminate (PCR+/Tox−) results for patients tested with a two-step algorithm for Clostridium difficile infection (CDI) is uncertain. We aimed to evaluate the clinical presentation and 8-week outcomes of patients with indeterminate test results. Patients with stool samples testing positive by PCR and negative by toxin A/B immunoassay between February 1, 2017, and April 30, 2018, were assessed by antimicrobial stewardship program (ASP) clinicians and classified as colonized or infected. Retrospective chart review was performed to obtain outcomes occurring within 8 weeks of testing, including recurrent C. difficile diarrhea, subsequent treatment for CDI, follow-up C. difficile testing, all-cause mortality, and CDI-related complications. In total, 110 PCR+/Tox− patients were evaluated. ASP classified 54% of patients as infected and 46% as colonized. Patients assessed and classified as colonized did not have increased adverse outcomes by 8 weeks compared to those assessed as infected, despite not receiving treatment for CDI. We conclude that PCR+/Tox− patients are heterogeneous with respect to clinical presentation. Negative toxin A/B immunoassay in a two-step algorithm should not be interpreted in isolation to distinguish colonization from infection as many PCR+/Tox− results may be clinically significant for CDI.Keywords
This publication has 17 references indexed in Scilit:
- Protective Factors in the Intestinal Microbiome Against Clostridium difficile Infection in Recipients of Allogeneic Hematopoietic Stem Cell TransplantationThe Journal of Infectious Diseases, 2017
- Point-Counterpoint: What Is the Optimal Approach for Detection of Clostridium difficile Infection?Journal of Clinical Microbiology, 2017
- European Society of Clinical Microbiology and Infectious Diseases: update of the diagnostic guidance document for Clostridium difficile infectionClinical Microbiology & Infection, 2016
- Overdiagnosis ofClostridium difficileInfection in the Molecular Test EraJAMA Internal Medicine, 2015
- Administration of Spores of NontoxigenicClostridium difficileStrain M3 for Prevention of RecurrentC difficileInfectionPublished by American Medical Association (AMA) ,2015
- Loss of Microbiota-Mediated Colonization Resistance toClostridium difficileInfection With Oral Vancomycin Compared With MetronidazoleThe Journal of Infectious Diseases, 2015
- Laboratory and Clinical features of EIA Toxin-positive and EIA Toxin-negative Community-acquired Clostridium difficile Infection.2015
- Clinical relevance of a positive molecular test in the diagnosis of Clostridium difficile infectionJournal of Hospital Infection, 2013
- Polymerase chain reaction assay to detect Clostridium difficile tcdC variants is valuable in characterizing hospital epidemiologyJournal of Hospital Infection, 2013
- Overcoming barriers to effective recognition and diagnosis of Clostridium difficile infectionClinical Microbiology & Infection, 2012